Effects of Platelet in the treatment of wounds in patients with Diabetes

Not Applicable

Recruiting

• Conditions: ower limb ulcer, not elsewhere classified; Diabetes Mellitus; C18.452.394.750

• Registration Number: RBR-6yt2hp
• Lead Sponsor: niversidade Brasil

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-02-20
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Type I Diabetes Mellitus Type II; Chronic wound carrier (over 12 weeks) Both sexes; Age between 30 to 70 years; Controlled blood glucose; Normal peripheral platelet count.

Exclusion Criteria

Use of oral anticoagulants, Wound with osteomyelitis and / or with exposure of tendons or bones; Wound with local gangrene or close to the anatomical site. Patients with bleeding tendencies; Uncontrolled DM (HBA1C greater than 7.5); Serum albumin less than 2.5 g / dL; Hemoglobin less than 10.5 mg / dL; Malignant neoplasms; Lupus erythematosus; Pregnancy and lactation

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
time, in weeks, for the treatment to promote the reepithelization and healing of chronic wounds of diabetic patients.

Secondary Outcome Measures

Name	Time	Method
Secondary 1: monitor, evaluate and analyze the use of the autologous PRP gel with optional therapy for the care of granulation and healing of chronic wounds in diabetic patients.<br>;Secondary 2: Evaluation of the quality of life of the patients being followed up in the study on the measurement of the type of pain at the beginning and at the end of the study using the validated Scale Verbal Numerica and LANSS, respectively.<br>